Peripheral Arterial Disease
Concept
Vocabulary Service
Overview
subject area of
-
A MultiCenter Pilot Randomized Controlled Trial of Remote Ischemic Preconditioning in Major Vascular Surgery Academic Article
-
Anticoagulation therapy in 2015: where we are and where we are going Academic Article
-
Antithrombotic Agents Academic Article
-
Antithrombotic Therapy for Peripheral Artery Disease Academic Article
-
Antithrombotics in stable peripheral artery disease Academic Article
-
Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis Academic Article
-
COMPASS for Vascular Surgeons Academic Article
-
Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up Academic Article
-
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk Academic Article
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 Academic Article
-
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Academic Article
-
Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology. Academic Article
-
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial Academic Article
-
Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial Academic Article
-
Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes Academic Article
-
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry Academic Article
-
External applicability of the COMPASS trial: the Western Denmark Heart Registry Academic Article
-
How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland Academic Article
-
Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study Academic Article
-
Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy Academic Article
-
Leukotrienes biosynthesis in vascular surgery patients during perioperative period. Academic Article
-
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease Academic Article
-
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin Academic Article
-
Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study Academic Article
-
New developments in anticoagulants: Past, present and future Academic Article
-
Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorised by TASC classification Academic Article
-
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia Academic Article
-
Patients with Peripheral Artery Disease in the COMPASS Trial Academic Article
-
Position Statement on Noninvasive Imaging of Peripheral Arterial Disease by the Society of Interventional Radiology and the Canadian Interventional Radiology Association Academic Article
-
Prevalence of peripheral arterial disease diagnosed by ankle brachial index among chronic kidney disease patients in a tertiary care unit Academic Article
-
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD) Academic Article
-
Real-Time Quantitative Measurements of Foot Perfusion in Patients With Critical Limb Ischemia Academic Article
-
Review of aspirin and clopidogrel resistance in peripheral arterial disease Academic Article
-
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial Academic Article
-
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction Academic Article
-
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease Academic Article
-
Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios Academic Article
-
Rivaroxaban in Peripheral Artery Disease after Revascularization Academic Article
-
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Academic Article
-
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin Academic Article
-
Stroke Outcomes in the COMPASS Trial Academic Article
-
Subintimal recanalization of peripheral chronic occlusive arterial disease with modified transseptal needle Academic Article
-
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease Academic Article
-
The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era Academic Article
-
The use of local anesthesia to perform lower limb revascularization in the fragile patient with critical limb ischemia. Academic Article
-
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study Academic Article
-
Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease Academic Article
-
Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes Academic Article
-
Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both Academic Article
-
miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery Academic Article